omeprazole has been researched along with Acute Disease in 101 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6-month treatment-free period in patients with active duodenal ulcer." | 9.09 | The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. ( Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L, 1999) |
| " Pantoprazole, 40 mg, was compared with the H2-receptor antagonist ranitidine, 300 mg, in the healing of acute duodenal ulcer." | 9.08 | A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group. ( Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C, 1995) |
| "Pantoprazole, 40 mg once daily in the morning, is a highly effective, well tolerated treatment for acute, benign gastric ulcer." | 9.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| "Pantoprazole is clinically superior to ranitidine in the treatment of acute duodenal ulcer, in terms of both healing and symptom relief." | 9.08 | Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. ( Classen, M; Schepp, W, 1995) |
| "To compare the healing rates of acute duodenal ulcer in patients receiving pantoprazole 40 mg or omeprazole 20 mg once daily and to assess drug tolerance." | 9.08 | Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. ( Beker, JA; Bianchi Porro, G; Bigard, MA; Delle Fave, G; Devis, G; Gouerou, H; Maier, C, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 9.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "Omeprazole, a potent inhibitor of acid secretion, is effective in adults with severe gastroesophageal reflux, but no such data are available on children." | 9.07 | Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. ( Gunasekaran, TS; Hassall, EG, 1993) |
| "In acute duodenal ulceration, treatment with lansoprazole 15 and 30 mg produced 4-wk healing rates and symptom relief superior to those produced by placebo and the 15-mg dose similar to those produced by placebo." | 9.07 | Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. ( Goff, J; Greski-Rose, P; Jennings, D; Lanza, F; Scowcroft, C, 1994) |
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 8.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| "All randomized clinical trials in which lansoprazole was used to treat patients with duodenal ulceration were reviewed." | 8.79 | Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. ( Agostini, H; Lemaire, M; Poynard, T, 1995) |
| "Omeprazole is an important cause of drug-induced acute interstitial nephritis (AIN)." | 7.80 | Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury? ( Berney-Meyer, L; Hung, N; Kitching, AR; Schollum, JB; Slatter, T; Walker, RJ, 2014) |
| "To determine the effects of prostaglandin E(2) alone and the combination with omeprazole for poisoning related acute mucosal lesion." | 7.75 | [Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]. ( Fan, X; Xu, Y; Zhang, H, 2009) |
| "To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis (AIN) due to pantoprazole." | 7.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "The study investigated the effect of either nocturnal acid suppression by the H2 antagonist nizatidine 300 mg at night or prolonged acid suppression by the proton- pump inhibitor omeprazole 20 mg in the morning, during four weeks, on intragastric pH profile, occurrence of bacterial growth in gastric fluid and biopsies, and healing rate in 23 patients with an acute duodenal ulcer." | 7.69 | Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer. ( Brummer, RJ; Stockbrügger, RW, 1996) |
| "Omeprazole is a proton pump inhibitor that is used commonly in the treatment of acid-peptic disorders." | 6.41 | Acute interstitial nephritis due to omeprazole. ( Hollomby, DJ; McLaughlin, K; Myers, RP, 2001) |
| "Acute generalized exanthematous pustulosis (AGEP) comprises a group of eruptions characterized by several small sterile pustules over an erythematous-edematous skin." | 5.35 | [Acute generalized exanthematous pustulosis induced by omeprazole]. ( Martínez-Peñuela Virseda, JM; Nantes Castillejo, O; Valcayo Peñalba, A; Zozaya Urmeneta, JM, 2008) |
| "Acute interstitial nephritis is an uncommon but important cause of acute renal failure." | 5.33 | Rabeprazole-induced acute interstitial nephritis. ( Coleman, PL; Geevasinga, N; Roger, SD, 2005) |
| "Omeprazole is a proton pump inhibitor widely used for the treatment of peptic ulcer disease." | 5.30 | Omeprazole-induced acute interstitial nephritis. ( d'Adamo, G; Forte, F; Gangeri, F; Spinelli, C, 1997) |
| "Among the 15 patients with hemorrhagic acute gastritis who were randomly allocated to group A (eradication therapy) or group B (Lansoprazole, LPZ), 10 of them started to receive treatment within 1 day after the disease onset." | 5.09 | A short-term eradication therapy for Helicobacter pylori acute gastritis. ( Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T, 2000) |
| "To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6-month treatment-free period in patients with active duodenal ulcer." | 5.09 | The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. ( Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L, 1999) |
| "Pantoprazole is clinically superior to ranitidine in the treatment of acute duodenal ulcer, in terms of both healing and symptom relief." | 5.08 | Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. ( Classen, M; Schepp, W, 1995) |
| " Pantoprazole, 40 mg, was compared with the H2-receptor antagonist ranitidine, 300 mg, in the healing of acute duodenal ulcer." | 5.08 | A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group. ( Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C, 1995) |
| "To compare the healing rates of acute duodenal ulcer in patients receiving pantoprazole 40 mg or omeprazole 20 mg once daily and to assess drug tolerance." | 5.08 | Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. ( Beker, JA; Bianchi Porro, G; Bigard, MA; Delle Fave, G; Devis, G; Gouerou, H; Maier, C, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 5.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "Pantoprazole, 40 mg once daily in the morning, is a highly effective, well tolerated treatment for acute, benign gastric ulcer." | 5.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| "Omeprazole, a potent inhibitor of acid secretion, is effective in adults with severe gastroesophageal reflux, but no such data are available on children." | 5.07 | Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. ( Gunasekaran, TS; Hassall, EG, 1993) |
| "In acute duodenal ulceration, treatment with lansoprazole 15 and 30 mg produced 4-wk healing rates and symptom relief superior to those produced by placebo and the 15-mg dose similar to those produced by placebo." | 5.07 | Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. ( Goff, J; Greski-Rose, P; Jennings, D; Lanza, F; Scowcroft, C, 1994) |
| " pylori-positive gastroduodenal ulcer bleeding, which could be commenced intravenously after endoscopic diagnosis, and to assess the effect of omeprazole pretreatment on bacterial eradication." | 5.07 | Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study. ( Adamek, RJ; Freitag, M; Opferkuch, W; Rühl, GH; Wegener, M, 1994) |
| " Thalidomide is nowadays used for the treatment of several conditions including multiple myeloma (MM)." | 4.88 | Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature. ( Gonçalves, R; Lopes, J; Macedo, G; Sobrinho Simões, M; Vilas-Boas, F, 2012) |
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 4.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| "Data from double-blind, placebo-controlled trials involving more than 1000 patients demonstrate that short-term, high-dose omeprazole therapy is effective for reducing bleeding and transfusion requirements in patients with acute peptic ulcer bleeding." | 4.81 | Proton-pump inhibitors for acute peptic ulcer bleeding. ( Erstad, BL, 2001) |
| "All randomized clinical trials in which lansoprazole was used to treat patients with duodenal ulceration were reviewed." | 4.79 | Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. ( Agostini, H; Lemaire, M; Poynard, T, 1995) |
| "This study evaluates the effectiveness of gastric acid secretion inhibitors (omeprazole and ranitidine), gastric mucosal protectants (sucralfate) and anthelmintics (mebendazole and flubendazole) in treating anisakiasis in Wistar rats." | 4.02 | Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model. ( Arrebola, F; Gómez-Mateos, M; González, JM; Navarro, MC; Romero, MC; Valero, A, 2021) |
| "Omeprazole is an important cause of drug-induced acute interstitial nephritis (AIN)." | 3.80 | Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury? ( Berney-Meyer, L; Hung, N; Kitching, AR; Schollum, JB; Slatter, T; Walker, RJ, 2014) |
| "To determine the effects of prostaglandin E(2) alone and the combination with omeprazole for poisoning related acute mucosal lesion." | 3.75 | [Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]. ( Fan, X; Xu, Y; Zhang, H, 2009) |
| "To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis (AIN) due to pantoprazole." | 3.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "To study the long-term curative effects of suture plus proximal gastric vagotomy (PGV) and suture plus triad-therapy (omeprazole, amoxycillin and flagyl taken orally) for the treatment of duodenal ulcer with acute perforation." | 3.71 | [Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation]. ( Fang, L; Huang, S; Jiang, K; Jiang, X; Lin, N; Pan, W; Wan, Y; Xu, R, 2002) |
| "We investigated the effect of probucol, a lipid-lowering agent with antioxidant properties, on HCl plus ethanol-induced gastric mucosal injury and on the healing of acetic acid-induced gastric ulcers in rats." | 3.70 | Anti-ulcer effects of antioxidants: effect of probucol. ( Ishihara, M; Ito, M; Suzuki, Y, 1998) |
| "Omeprazole has been used with increasing frequency for the treatment of conditions such as reflux oesophagitis, peptic ulcer disease, and Zollinger-Ellison syndrome." | 3.70 | Omeprazole and the development of acute hepatitis. ( Koury, SI; La Charité, DD; Stone, CK, 1998) |
| " pylori lipopolysaccharide-induced acute gastritis to study the effect of antiulcer agents, omeprazole and sucralfate, on the course of mucosal inflammatory responses by analyzing the interplay between the extent of epithelial cell apoptosis and the mucosal expression of endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-alpha), and the activity of constitutive (cNOS) and inducible (NOS-2) nitric oxide synthase." | 3.70 | Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate. ( Piotrowski, J; Slomiany, A; Slomiany, BL, 2000) |
| "The study investigated the effect of either nocturnal acid suppression by the H2 antagonist nizatidine 300 mg at night or prolonged acid suppression by the proton- pump inhibitor omeprazole 20 mg in the morning, during four weeks, on intragastric pH profile, occurrence of bacterial growth in gastric fluid and biopsies, and healing rate in 23 patients with an acute duodenal ulcer." | 3.69 | Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer. ( Brummer, RJ; Stockbrügger, RW, 1996) |
| "On a randomly selected day the clinical charts of 3685 inpatients were reviewed by a gastroenterologist and data were collected concerning the drug used, its dosage and indications for the prescription." | 2.68 | Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study. ( Comin, U; Cortelezzi, C; Curzio, M; Ferrara, A; Ferraris, L; Gullotta, R; Minoli, G; Prada, A; Rocca, F, 1997) |
| " The results of studies comparing the clinical efficacy of different PPI dosage forms and routes of administration, safety considerations, and cost-effectiveness analyses are among the factors to consider when making formulary decisions for this class of drugs." | 2.43 | Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics. ( Devlin, JW; Olsen, KM; Welage, LS, 2005) |
| "Omeprazole is a proton pump inhibitor that is used commonly in the treatment of acid-peptic disorders." | 2.41 | Acute interstitial nephritis due to omeprazole. ( Hollomby, DJ; McLaughlin, K; Myers, RP, 2001) |
| "Acute massive gastric dilatation (AMGD) is a recognised complication after Nissen fundoplication." | 1.48 | Massive gastric dilatation leading to acute respiratory distress 1 year after a Nissen fundoplication. ( Alasadi, A; DiMaggio, F; Mukherjee, D; Sohrabi, F, 2018) |
| "Acute generalized exanthematous pustulosis (AGEP) comprises a group of eruptions characterized by several small sterile pustules over an erythematous-edematous skin." | 1.35 | [Acute generalized exanthematous pustulosis induced by omeprazole]. ( Martínez-Peñuela Virseda, JM; Nantes Castillejo, O; Valcayo Peñalba, A; Zozaya Urmeneta, JM, 2008) |
| " He was successfully treated by increasing his dosage of omeprazol (20 mg/day) for two weeks." | 1.35 | Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin. ( Azuhata, H; Katoh, H; Kuwano, H; Tsukada, K, 2009) |
| "Acute pancreatitis is a pancreatic inflammation that recognises Salmonella typhi among its aetiological agents." | 1.34 | [Typhoid fever and acute pancreatitis: two cases]. ( Bertuccio, SN; Rombolà, F, 2007) |
| "The diagnosis of GERD was confirmed in all patients by standard criteria." | 1.33 | Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. ( Canani, RB; Cirillo, P; Guarino, A; Malamisura, B; Manguso, F; Morelli, L; Passariello, A; Roggero, P; Romano, C; Terrin, G, 2006) |
| "Oesophagitis was induced by pyloric ligation in wild-type and VR-1 deficient mice." | 1.33 | Attenuation of acid induced oesophagitis in VR-1 deficient mice. ( de la Fuente, SG; Fujino, K; Mantyh, CR; Takahashi, T; Takami, Y, 2006) |
| "Acute interstitial nephritis is an uncommon but important cause of acute renal failure." | 1.33 | Rabeprazole-induced acute interstitial nephritis. ( Coleman, PL; Geevasinga, N; Roger, SD, 2005) |
| "Omeprazole was administered intraperitoneally, twice a day, for 3 days to the male rats in 0." | 1.31 | Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats. ( Burdan, F; Burski, K; Maciejewski, R; Siezieniewska, Z; Wójtowicz, Z, 2000) |
| "Omeprazole is a proton pump inhibitor widely used for the treatment of peptic ulcer disease." | 1.30 | Omeprazole-induced acute interstitial nephritis. ( d'Adamo, G; Forte, F; Gangeri, F; Spinelli, C, 1997) |
| "Pretreatment with omeprazole (30 mg/kg s." | 1.30 | Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress. ( Arakawa, T; Higuchi, K; Kobayashi, K; Kuroki, T; Takaishi, O; Yamasaki, K, 1999) |
| "Omeprazole is a powerful inhibitor of gastric acid and may suppress Helicobacter pylori by effecting the pKa of H pylori urease, by altering the pattern of infection, or by promoting overgrowth of other bacteria." | 1.29 | Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. ( Baron, JH; Gummett, PA; Karim, QN; Logan, RP; Misiewicz, JJ; Walker, MM, 1995) |
| "Lansoprazole was more potent than omeprazole, famotidine and ranitidine in inhibiting gastric mucosal lesions and hemorrhagic shock- or stress-induced bleeding." | 1.29 | [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion]. ( Asano, S; Inada, I; Inatomi, N; Murakami, I; Satoh, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.98) | 18.7374 |
| 1990's | 41 (40.59) | 18.2507 |
| 2000's | 41 (40.59) | 29.6817 |
| 2010's | 12 (11.88) | 24.3611 |
| 2020's | 5 (4.95) | 2.80 |
| Authors | Studies |
|---|---|
| Abu El-Ella, SS | 1 |
| El-Mekkawy, MS | 1 |
| Mohamed Selim, A | 1 |
| Collen, LV | 1 |
| Mitchell, PD | 1 |
| Fox, VL | 1 |
| Grover, AS | 1 |
| Gómez-Mateos, M | 1 |
| Arrebola, F | 1 |
| Navarro, MC | 1 |
| Romero, MC | 1 |
| González, JM | 1 |
| Valero, A | 1 |
| Parton, JR | 1 |
| Ritchie, J | 1 |
| Deliwala, SS | 1 |
| Gurvits, GE | 1 |
| Sohrabi, F | 1 |
| DiMaggio, F | 1 |
| Alasadi, A | 1 |
| Mukherjee, D | 1 |
| Baracho, NC | 1 |
| Ribeiro, RV | 1 |
| Pereira, RM | 1 |
| Irulegui, Rde S | 1 |
| Berney-Meyer, L | 1 |
| Hung, N | 1 |
| Slatter, T | 1 |
| Schollum, JB | 1 |
| Kitching, AR | 1 |
| Walker, RJ | 1 |
| Wang, L | 1 |
| Zhang, H | 2 |
| Li, C | 1 |
| Yi, Y | 1 |
| Liu, J | 1 |
| Zhao, Y | 1 |
| Tian, J | 1 |
| Zhang, Y | 1 |
| Wei, X | 1 |
| Gao, Y | 1 |
| Liang, A | 1 |
| Iwańczak, B | 1 |
| Stawarski, A | 1 |
| Hutyra, T | 1 |
| Mowszet, K | 1 |
| Iwańczak, F | 1 |
| Wawro, J | 1 |
| Castelluccio, MS | 1 |
| Hermida, R | 1 |
| Ayunta, H | 1 |
| Manzotti, L | 1 |
| Cháves, E | 1 |
| Romo, R | 1 |
| Perelstein, G | 1 |
| Tsukada, K | 1 |
| Azuhata, H | 1 |
| Katoh, H | 1 |
| Kuwano, H | 1 |
| Fan, X | 1 |
| Xu, Y | 1 |
| Ray, S | 1 |
| Delaney, M | 1 |
| Muller, AF | 1 |
| Schaffer, AC | 1 |
| Grad, Y | 1 |
| Ross, JJ | 1 |
| Ni, N | 1 |
| Moeckel, GW | 1 |
| Kumar, C | 1 |
| Chan, WH | 1 |
| Khin, LW | 1 |
| Chung, YF | 1 |
| Goh, YC | 1 |
| Ong, HS | 1 |
| Wong, WK | 1 |
| Piñero Rodríguez, AM | 1 |
| Alvarez López, A | 1 |
| Nadal Reus, J | 1 |
| Mumtaz, K | 1 |
| Kamani, L | 1 |
| Hamid, S | 1 |
| Abid, S | 1 |
| Shah, HA | 1 |
| Jafri, W | 1 |
| Vilas-Boas, F | 1 |
| Gonçalves, R | 1 |
| Sobrinho Simões, M | 1 |
| Lopes, J | 1 |
| Macedo, G | 1 |
| Hrabovský, V | 1 |
| Mendlová, A | 1 |
| Zadák, Z | 1 |
| Bláha, V | 1 |
| Hyšpler, R | 1 |
| Tichá, A | 1 |
| Svagera, Z | 1 |
| Xu, R | 1 |
| Fang, L | 1 |
| Jiang, X | 1 |
| Wan, Y | 1 |
| Huang, S | 1 |
| Jiang, K | 1 |
| Lin, N | 1 |
| Pan, W | 1 |
| Tashiro, M | 1 |
| Yoshikawa, I | 1 |
| Kume, K | 1 |
| Narita, R | 1 |
| Sugihara, Y | 1 |
| Otsuki, M | 1 |
| Ra, A | 1 |
| Tobe, SW | 1 |
| Likic, R | 1 |
| Kuzmanic, D | 1 |
| Torregrosa, E | 1 |
| Rovira, RE | 1 |
| Calvo, C | 1 |
| Hernández-Jaras, J | 1 |
| Maduell, F | 1 |
| García, H | 1 |
| Enns, R | 1 |
| Andrews, CN | 1 |
| Fishman, M | 1 |
| Hahn, M | 1 |
| Atkinson, K | 1 |
| Kwan, P | 1 |
| Levy, A | 1 |
| Elizalde, JI | 1 |
| Pérez-Pujol, S | 1 |
| Heras, M | 1 |
| Sionis, A | 1 |
| Casanovas, N | 1 |
| Martorell, T | 1 |
| Lozano, M | 1 |
| González, J | 1 |
| Escolar, G | 1 |
| Sanz, G | 1 |
| Piqué, JM | 1 |
| Geevasinga, N | 1 |
| Coleman, PL | 1 |
| Roger, SD | 1 |
| Fujino, K | 1 |
| de la Fuente, SG | 1 |
| Takami, Y | 1 |
| Takahashi, T | 1 |
| Mantyh, CR | 1 |
| Gostishchev, VK | 1 |
| Evseev, MA | 1 |
| Devlin, JW | 1 |
| Welage, LS | 1 |
| Olsen, KM | 1 |
| Güliter, S | 1 |
| Keleş, H | 1 |
| Ozkurt, ZN | 1 |
| Cengiz, DU | 1 |
| Kolukisa, E | 1 |
| Glazunov, VK | 1 |
| Rumiantsev, GV | 1 |
| Buka, GIu | 1 |
| Brikman, AE | 1 |
| Sumishevskiĭ, EV | 1 |
| Kondrat'eva, AB | 1 |
| Tuccori, M | 1 |
| Giovannoni, S | 1 |
| Giustini, SE | 1 |
| Blandizzi, C | 1 |
| Del Tacca, M | 1 |
| Jacobs-Kosmin, D | 1 |
| Derk, CT | 1 |
| Sandorfi, N | 1 |
| Canani, RB | 1 |
| Cirillo, P | 1 |
| Roggero, P | 1 |
| Romano, C | 1 |
| Malamisura, B | 1 |
| Terrin, G | 1 |
| Passariello, A | 1 |
| Manguso, F | 1 |
| Morelli, L | 1 |
| Guarino, A | 1 |
| Melo, JR | 1 |
| de Araújo, GK | 1 |
| da Luz, MM | 1 |
| da Conceição, SA | 1 |
| Lisboa, FA | 1 |
| Moraes-Santos, T | 1 |
| Cunha-Melo, JR | 1 |
| Keyvani, L | 1 |
| Murthy, S | 1 |
| Leeson, S | 1 |
| Targownik, LE | 1 |
| Lin, HJ | 1 |
| Sánchez Garrido, A | 1 |
| Rombolà, F | 1 |
| Bertuccio, SN | 1 |
| Lai, KC | 1 |
| Cheng, CH | 1 |
| Leung, PS | 1 |
| Nantes Castillejo, O | 1 |
| Zozaya Urmeneta, JM | 1 |
| Valcayo Peñalba, A | 1 |
| Martínez-Peñuela Virseda, JM | 1 |
| Blanchi, A | 1 |
| Delchier, JC | 1 |
| Soule, JC | 1 |
| Payen, D | 1 |
| Bader, JP | 1 |
| Schepp, W | 2 |
| Classen, M | 1 |
| Beker, JA | 1 |
| Bianchi Porro, G | 1 |
| Bigard, MA | 2 |
| Delle Fave, G | 2 |
| Devis, G | 1 |
| Gouerou, H | 1 |
| Maier, C | 2 |
| Choné, L | 1 |
| Fléjou, JF | 1 |
| Grignon, Y | 1 |
| Hotz, J | 1 |
| Plein, K | 1 |
| Schönekäs, H | 1 |
| Rose, K | 1 |
| Witzel, L | 1 |
| Gütz, H | 1 |
| Hüttemann, W | 1 |
| Cremer, M | 1 |
| Lambert, R | 1 |
| Lamers, CB | 1 |
| Assouad, M | 1 |
| Vicks, SL | 1 |
| Pokroy, MV | 1 |
| Willcourt, RJ | 1 |
| Adamek, RJ | 1 |
| Freitag, M | 1 |
| Opferkuch, W | 1 |
| Rühl, GH | 1 |
| Wegener, M | 1 |
| Lewis, CR | 1 |
| Somerville, C | 1 |
| Agar, JW | 1 |
| Kraus, A | 1 |
| Flores-Suárez, LF | 1 |
| Logan, RP | 1 |
| Walker, MM | 1 |
| Misiewicz, JJ | 1 |
| Gummett, PA | 1 |
| Karim, QN | 1 |
| Baron, JH | 1 |
| Goletti, O | 1 |
| Sidoti, F | 1 |
| Lippolis, PV | 1 |
| De Negri, F | 1 |
| Cavina, E | 1 |
| Alarcón de la Lastra, C | 1 |
| Martín, MJ | 1 |
| La Casa, C | 1 |
| Motilva, V | 1 |
| Jones, B | 1 |
| Hewson, E | 1 |
| Price, A | 1 |
| Lanza, F | 1 |
| Goff, J | 1 |
| Scowcroft, C | 1 |
| Jennings, D | 1 |
| Greski-Rose, P | 1 |
| Gunasekaran, TS | 1 |
| Hassall, EG | 1 |
| Kuiper, JJ | 1 |
| Fleury, D | 1 |
| Storkebaum, H | 1 |
| Mougenot, B | 1 |
| Bridoux, F | 1 |
| Gobert, P | 1 |
| Lemaitre, V | 1 |
| Vanhille, P | 1 |
| Poynard, T | 1 |
| Lemaire, M | 1 |
| Agostini, H | 1 |
| Brummer, RJ | 1 |
| Stockbrügger, RW | 1 |
| Mathias, SD | 1 |
| Castell, DO | 1 |
| Elkin, EP | 1 |
| Matosian, ML | 1 |
| Inatomi, N | 1 |
| Murakami, I | 1 |
| Asano, S | 1 |
| Inada, I | 1 |
| Satoh, H | 1 |
| d'Adamo, G | 1 |
| Spinelli, C | 1 |
| Forte, F | 1 |
| Gangeri, F | 1 |
| Skála, I | 1 |
| Marecková, O | 1 |
| Vítko, S | 1 |
| Matl, I | 1 |
| Lácha, J | 1 |
| Badov, D | 1 |
| Perry, G | 1 |
| Lambert, J | 1 |
| Dowling, J | 1 |
| Navarro, JF | 1 |
| Gallego, E | 1 |
| Avilés, J | 1 |
| Nakamoto, K | 1 |
| Wada, K | 1 |
| Kitano, M | 1 |
| Kishimoto, Y | 1 |
| Ashida, K | 1 |
| Kamisaki, Y | 1 |
| Kawasaki, H | 1 |
| Itoh, T | 1 |
| Gullotta, R | 1 |
| Ferraris, L | 1 |
| Cortelezzi, C | 1 |
| Minoli, G | 1 |
| Prada, A | 1 |
| Comin, U | 1 |
| Rocca, F | 1 |
| Ferrara, A | 1 |
| Curzio, M | 1 |
| King, VJ | 1 |
| Hayashibara, T | 1 |
| Ito, M | 1 |
| Suzuki, Y | 2 |
| Ishihara, M | 1 |
| Koury, SI | 1 |
| Stone, CK | 1 |
| La Charité, DD | 1 |
| Zanten, SJ | 1 |
| Bradette, M | 1 |
| Farley, A | 1 |
| Leddin, D | 1 |
| Lind, T | 1 |
| Unge, P | 1 |
| Bayerdörffer, E | 1 |
| Spiller, RC | 1 |
| O'Morain, C | 1 |
| Sipponen, P | 1 |
| Wrangstadh, M | 1 |
| Zeijlon, L | 1 |
| Sinclair, P | 1 |
| Yamasaki, K | 1 |
| Arakawa, T | 1 |
| Takaishi, O | 1 |
| Higuchi, K | 1 |
| Kobayashi, K | 1 |
| Kuroki, T | 1 |
| Benoit, R | 1 |
| Grobost, O | 1 |
| Geetha, D | 1 |
| Brzozowski, T | 2 |
| Konturek, PC | 1 |
| Konturek, SJ | 2 |
| Drozdowicz, D | 1 |
| Kwiecieñ, S | 1 |
| Pajdo, R | 1 |
| Bielanski, W | 1 |
| Hahn, EG | 1 |
| Slomiany, BL | 1 |
| Piotrowski, J | 1 |
| Slomiany, A | 1 |
| Di Mario, F | 1 |
| Battaglia, F | 1 |
| Dal Bò, N | 1 |
| Leandro, G | 1 |
| Benedetti, E | 1 |
| Bottona, E | 1 |
| Caroli, A | 1 |
| Costan-Biedo, F | 1 |
| De Bastiani, R | 1 |
| Germanà, B | 1 |
| Andrea Grassi, S | 1 |
| Madia, D | 1 |
| Marcon, V | 1 |
| Marin, R | 1 |
| Monica, F | 1 |
| Olivieri, P | 1 |
| Orzes, N | 1 |
| Pilotto, A | 1 |
| Ronzani, G | 1 |
| Saggioro, A | 1 |
| Tafner, G | 1 |
| Wall, CA | 1 |
| Gaffney, EF | 1 |
| Mellotte, GJ | 1 |
| Burdan, F | 1 |
| Siezieniewska, Z | 1 |
| Maciejewski, R | 1 |
| Burski, K | 1 |
| Wójtowicz, Z | 1 |
| Nomura, H | 1 |
| Miyake, K | 1 |
| Kashiwagi, S | 1 |
| Sugiyama, T | 1 |
| Asaka, M | 1 |
| Reichart, M | 1 |
| Busch, OR | 1 |
| Bruno, MJ | 1 |
| Van Lanschot, JJ | 1 |
| Erstad, BL | 1 |
| Myers, RP | 1 |
| McLaughlin, K | 1 |
| Hollomby, DJ | 1 |
| Fasseas, P | 1 |
| Leybishkis, B | 1 |
| Rocca, G | 1 |
| Martínez-Chamorro, C | 1 |
| Martínez, E | 1 |
| Gil-Fernández, JJ | 1 |
| Escudero, A | 1 |
| Acevedo, A | 1 |
| Fernández-Rañada, JM | 1 |
| Andrade, RJ | 1 |
| Lucena, MI | 1 |
| Sakaki, N | 1 |
| Ruffenach, SJ | 1 |
| Siskind, MS | 1 |
| Lien, YH | 1 |
| Cox, NH | 1 |
| Oddsson, E | 1 |
| Gudjónsson, H | 1 |
| Thjódleifsson, B | 1 |
| Pace, V | 1 |
| Fidanza, F | 1 |
| Zechini, F | 1 |
| Garlicki, J | 1 |
| Majka, J | 1 |
| Stachura, J | 1 |
| Nauert, C | 1 |
| Collier, DS | 1 |
| Crampton, J | 1 |
| Everett, WG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravenous Infusion of High Dose Omeprazole Versus Regular Dose Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers[NCT00519519] | Phase 3 | 126 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for omeprazole and Acute Disease
| Article | Year |
|---|---|
Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemical and Drug Induc | 2012 |
Proton pump inhibitors for acute upper GI bleeding.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Gastrointestinal Hemorrhage; Humans; Middle Aged; Omeprazole | 2004 |
[Acute interstitial nephritis associated with omeprazole therapy].
Topics: Acute Disease; Aged; Combined Modality Therapy; Enzyme Inhibitors; Female; Gastroesophageal Reflux; | 2004 |
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Capsules; Humans; Lansopr | 2005 |
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Duodenal Ulcer; Famotidin | 1995 |
[Black esophagus related to acute esophageal necrosis: a new case].
Topics: Acute Disease; Anti-Ulcer Agents; Combined Modality Therapy; Duodenal Ulcer; Esophagoscopy; Esophagu | 1999 |
Proton-pump inhibitors for acute peptic ulcer bleeding.
Topics: Acute Disease; Anti-Ulcer Agents; Hemorrhage; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibito | 2001 |
Acute interstitial nephritis due to omeprazole.
Topics: Acute Disease; Adult; Female; Humans; Kidney; Nephritis, Interstitial; Omeprazole; Proton Pump Inhib | 2001 |
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclospo | 2002 |
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].
Topics: Acute Disease; Amoxicillin; Clarithromycin; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Helic | 2002 |
19 trials available for omeprazole and Acute Disease
| Article | Year |
|---|---|
Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
Topics: Acute Disease; Anti-Ulcer Agents; Female; Gastroscopy; Hemostasis, Surgical; Humans; Infusions, Intr | 2011 |
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.
Topics: Acute Disease; Amoxicillin; Antigens, CD; Coronary Disease; Female; Helicobacter Infections; Helicob | 2004 |
Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Ulcer A | 1995 |
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Ad | 1995 |
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 | 1995 |
A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; | 1995 |
Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Carb | 1994 |
Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial.
Topics: Acute Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulce | 1994 |
Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Anti-Ulcer Agents; Double-Blind Metho | 1994 |
Efficacy and safety of omeprazole for severe gastroesophageal reflux in children.
Topics: Acute Disease; Adolescent; Biopsy; Capsules; Child; Child, Preschool; Endoscopy, Gastrointestinal; E | 1993 |
Health-related quality of life of patients with acute erosive reflux esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Analysis of Variance; Double-Blind Method; E | 1996 |
Prophylaxis of acute gastroduodenal bleeding after renal transplantation.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; | 1997 |
Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study.
Topics: Acute Disease; Anti-Ulcer Agents; Cohort Studies; Cytoprotection; Drug Prescriptions; Drug Utilizati | 1997 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-B | 1999 |
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; | 2000 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Ant | 2000 |
Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Endoscopy, Digestive System; Female; Gastrointestinal | 2001 |
Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
Topics: Acute Disease; Adult; Double-Blind Method; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mu | 1992 |
72 other studies available for omeprazole and Acute Disease
| Article | Year |
|---|---|
Stress ulcer prophylaxis for critically ill children: routine use needs to be re-examined.
Topics: Acute Disease; Child; Critical Illness; Gastrointestinal Hemorrhage; Humans; Omeprazole; Peptic Ulce | 2022 |
Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients With Acute Pancreatitis.
Topics: Acute Disease; Child; Hospitalization; Humans; Omeprazole; Pancreatitis; Retrospective Studies; Youn | 2023 |
Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model.
Topics: Acute Disease; Animals; Anisakiasis; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Disease | 2021 |
Acute upper gastrointestinal bleed in the puerperium following weight reduction surgery.
Topics: Acute Disease; Adult; Bariatric Surgery; Female; Gastrointestinal Hemorrhage; Gastroscopy; Humans; I | 2020 |
Acute Esophageal Necrosis in a Patient With COVID-19.
Topics: Acute Disease; COVID-19; Drug Therapy, Combination; Endoscopy, Digestive System; Esophagus; Humans; | 2021 |
Massive gastric dilatation leading to acute respiratory distress 1 year after a Nissen fundoplication.
Topics: Abdominal Pain; Acute Disease; Endoscopy, Digestive System; Fundoplication; Gastric Dilatation; Huma | 2018 |
Effects of the administration of aqueous extract of de Sedum dendroideum on the histopathology of erosive induced gastritis by means of indomethacin in rats.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Gastric Mucosa; Gastritis; Ind | 2014 |
Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?
Topics: Acute Disease; Aged; Aged, 80 and over; Biopsy; Eosinophils; Female; Humans; Immunophenotyping; Male | 2014 |
Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity.
Topics: Acute Disease; Animals; Aristolochia; Aristolochic Acids; Cytochrome P-450 CYP1A1; Epithelial Cells; | 2016 |
[Acute pancreatitis as a complication of diagnostic gastroduodenal endoscopy at 10 years old girl--case report].
Topics: Acute Disease; Child; Endoscopy, Gastrointestinal; Female; Humans; Omeprazole; Pancreatitis; Pancrea | 2008 |
[Upper gastrointestinal bleeding of infrequent cause].
Topics: Acute Disease; Aged, 80 and over; Ampicillin; Anti-Ulcer Agents; Esophagitis; Fatal Outcome; Gastroi | 2008 |
Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin.
Topics: Accidents, Home; Acute Disease; Aged; Aniline Compounds; Anti-Ulcer Agents; Duodenal Diseases; Herbi | 2009 |
[Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion].
Topics: Acute Disease; Animals; Dinoprostone; Enzyme Inhibitors; Female; Gastric Mucosa; Male; Omeprazole; O | 2009 |
Proton pump inhibitors and acute interstitial nephritis.
Topics: Acute Disease; Aged; Female; Humans; Middle Aged; Nephritis, Interstitial; Omeprazole; Proton Pump I | 2010 |
Interactive medical case. Bitter pills.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Creatini | 2010 |
Late-onset omeprazole-associated acute interstitial nephritis.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Biopsy; Female; Humans; Nephritis, Interstitial; Omeprazole; | 2010 |
[Atypical manifestations of acute posterior placoid pigment epitheliopathy].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cysts; Drug Therapy, Combination; Fluorescein Angiog | 2010 |
Impact of a bleeding care pathway in the management of acute upper gastrointestinal bleeding.
Topics: Acute Disease; Adult; Aged; Case-Control Studies; Critical Pathways; Endoscopy; Female; Gastrointest | 2011 |
Cholesterol metabolism in acute upper gastrointestinal bleeding, preliminary observations.
Topics: Acute Disease; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Combined Modal | 2012 |
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Fema | 2002 |
Acute hyperkalemia associated with intravenous omeprazole therapy.
Topics: Acute Disease; Anti-Ulcer Agents; Gastroscopy; Humans; Hyperkalemia; Injections, Intravenous; Male; | 2003 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; | 2004 |
Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Follow-Up | 2004 |
Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Aged, 80 and over; Anti-Ulcer Agents; | 2004 |
Rabeprazole-induced acute interstitial nephritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Acute Kidney Injury; Anti-Ulcer Agents; Benz | 2005 |
Attenuation of acid induced oesophagitis in VR-1 deficient mice.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Capsaicin; Endocytosis; Esophagitis; Famotidine; Hydrogen | 2006 |
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Hum | 2005 |
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; A | 2005 |
[Application of the proton pump inhibitors in treatment of an acute gastro-intestinal bleeding of the ulcer etiology].
Topics: Acute Disease; Adult; Aged; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Ma | 2005 |
Acute severe myopathy following a single infusion of omeprazole.
Topics: Acute Disease; Aged; Humans; Infusions, Intravenous; Male; Muscular Diseases; Omeprazole; Proton Pum | 2006 |
Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Antibodies, Antineu | 2006 |
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Topics: Achlorhydria; Acute Disease; Anti-Ulcer Agents; Child, Preschool; Community-Acquired Infections; Gas | 2006 |
Effect of acid secretion blockade on acute gastric mucosal lesions induced by Tityus serrulatus scorpion toxin in anaesthetized rats.
Topics: Acute Disease; Anesthesia; Animals; Atropine; Cimetidine; Dose-Response Relationship, Drug; Drug Ant | 2006 |
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and ove | 2006 |
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and ove | 2007 |
[Omeprazole-induced acute cholestatic hepatitis].
Topics: Acute Disease; Adult; Anti-Ulcer Agents; Chemical and Drug Induced Liver Injury; Cholestasis, Intrah | 2007 |
[Typhoid fever and acute pancreatitis: two cases].
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Ceftriaxone; Female; | 2007 |
The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas.
Topics: Achlorhydria; Acute Disease; Animals; Autocrine Communication; Ceruletide; Food Deprivation; Gastric | 2007 |
[Acute generalized exanthematous pustulosis induced by omeprazole].
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Eruptions; Exanthema; Female; Humans; Male; Middle Aged | 2008 |
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole.
Topics: Acute Disease; Adult; Benzimidazoles; Humans; Injections, Intravenous; Male; Omeprazole; Zollinger-E | 1982 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy | 1995 |
Recurrent acute interstitial nephritis on rechallenge with omeprazole.
Topics: Acute Disease; Aged; Humans; Male; Nephritis, Interstitial; Omeprazole; Recurrence | 1994 |
Omeprazole induced acute interstitial nephritis.
Topics: Acute Disease; Aged; Female; Humans; Nephritis, Interstitial; Omeprazole | 1994 |
Acute gout associated with omeprazole.
Topics: Acute Disease; Adult; Duodenal Ulcer; Gout; Humans; Male; Middle Aged; Omeprazole | 1995 |
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Breath Tests; Chronic Disease; Duodenal Ulcer; Esophagitis, | 1995 |
Antiulcerogenicity of the flavonoid fraction from Bidens aurea: comparison with ranitidine and omeprazole.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cold Temperature; Disease Models, Animal; Female; Flavono | 1994 |
Acute interstitial nephritis due to omeprazole.
Topics: Acute Disease; Aged; Female; Humans; Nephritis, Interstitial; Omeprazole | 1994 |
Omeprazole-induced acute interstitial nephritis.
Topics: Acute Disease; Female; Humans; Middle Aged; Nephritis, Interstitial; Omeprazole | 1993 |
Acute interstitial nephritis due to omeprazole.
Topics: Acute Disease; Aged; Enzyme Inhibitors; Humans; Male; Nephritis, Interstitial; Omeprazole | 1995 |
Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Bacteria; Drug Administration Schedule; Drug Therapy, | 1996 |
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Animals; Anti-Ulcer Agents; Famotidine; Gast | 1996 |
Omeprazole-induced acute interstitial nephritis.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Biopsy; Blood Urea Nitrogen; Creatinine; Duodenal Ulcer; Fem | 1997 |
Acute interstitial nephritis secondary to omeprazole.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Female; Humans; Male; Nephritis, Interstitial; Omeprazole | 1997 |
Recurrent severe acute hepatitis and omeprazole.
Topics: Acute Disease; Adult; Anti-Ulcer Agents; Chemical and Drug Induced Liver Injury; Humans; Male; Omepr | 1997 |
The role of endogenous acid in the development of acute gastric ulcer induced by ischemia-reperfusion in the rat.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cimetidine; Gastric Acid; Gastric Mucosa; Ischemia; Male; | 1998 |
PPIs vs H2RAs for erosive reflux esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Cost-Benefit Analysis; Enzyme Inhibitors; Es | 1998 |
[Hemolytic anemia and thrombocytopenia associated with anti-omeprazole antibody].
Topics: Acute Disease; Aged; Aged, 80 and over; Anemia, Hemolytic; Anti-Ulcer Agents; Antibodies; Esophagiti | 1998 |
Anti-ulcer effects of antioxidants: effect of probucol.
Topics: Acetic Acid; Acute Disease; Animals; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Cimetidine; D | 1998 |
Omeprazole and the development of acute hepatitis.
Topics: Acute Disease; Adult; Anti-Ulcer Agents; Chemical and Drug Induced Liver Injury; Emergency Treatment | 1998 |
Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catalas | 1999 |
Omeprazole-induced acute interstitial nephritis.
Topics: Acute Disease; Acute Kidney Injury; Aged; Anti-Ulcer Agents; Blood Urea Nitrogen; Creatinine; Diagno | 1999 |
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Blood Flow Velocity; Disease Progression; Gastric Acid; G | 2000 |
Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Apoptosis; Endothelin-1; Gastric Mucosa; Gastritis; Helic | 2000 |
Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Female; Humans; Hypercalcemia; Nephritis, Interstiti | 2000 |
Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Lysosomes; Male; Omeprazole; Pancreas; Pancreatitis; Rats | 2000 |
Black esophagus: a view in the dark.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Esophageal Diseases; Esophagus; Gastric Outlet Obstruction; | 2000 |
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Biopsy, Needle; Chemical and | 2002 |
Acute interstitial nephritis due to omeprazole.
Topics: Acute Disease; Aged; Esophagitis, Peptic; Female; Humans; Nephritis, Interstitial; Omeprazole | 1992 |
Acute disseminated epidermal necrosis due to omeprazole.
Topics: Acute Disease; Aged; Diagnosis, Differential; Erythema Multiforme; Female; Humans; Omeprazole; Pemph | 1992 |
[Omeprazole and misoprostol in acute gastroduodenal pathology. Physiopathological and therapeutic considerations in a surgical study].
Topics: Acute Disease; Humans; Misoprostol; Omeprazole; Peptic Ulcer | 1992 |
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids.
Topics: Acute Disease; Aluminum Hydroxide; Animals; Antacids; Chronic Disease; Drug Combinations; Ethanol; F | 1991 |
Acute haemorrhagic gastritis controlled by omeprazole.
Topics: Acute Disease; Gastritis; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole | 1989 |